Penn Center for Innovation

B.PHL Recap: Making the most of innovation in our backyard

Posted on October 21, 2019 — Jessica Jones Gupta

Philly was abuzz with activity this week with the launch of the first annual B.PHL innovation festival.  The 3-day long festival featured more than 200 panels, workshops, and events and stretched from Temple to Center City, University City, and Grey’s Ferry. Penn participated in B.PHL as a marketing partner, via panels, and as a host…

Two Penn teams named finalists in the Science Center’s QED Proof-of-Concept Program

Posted on October 18, 2019 — Jessica Jones Gupta

The University City Science Center has named 10 finalists in its 2019 QED proof-of-concept program, which partners with regional academic and research institutions to prepare their most promising life science technologies for commercialization. The two finalists from Penn are: A new method for removing devices from the bloodstream and heart, Lead Investigator Matt Gillespie A…

Philadelphia is having its best year for VC deals since 2000

Posted on October 17, 2019 — Jessica Jones Gupta

Ninety-three percent of raises came from heath and medical care companies. At the close of the third quarter of 2019, Philadelphia is having its best year in terms of deals in the region in nearly two decades, according to a recent PricewaterhouseCoopers (PwC)/CB Insights MoneyTree report. Read more. (Technical.ly Philly)

President’s Innovation Prize deadline is January 24, 2020

Posted on October 16, 2019 — Jessica Jones Gupta

Created by Penn President Amy Gutmann to strengthen Penn’s commitment under the Penn Compact 2020 to innovation, the President’s Innovation Prize will provide a graduating senior, or team of graduating seniors, $100,000 (plus a $50,000 living stipend per team member) to envision and implement an innovative, commercial venture that makes a positive difference in the…

Gene therapy for Duchenne muscular dystrophy safely preserves muscle function

Posted on October 9, 2019 — Jessica Jones Gupta

A Penn study shows delivering a ‘distant cousin’ of a key protein prevented muscle damage without triggering an immune response in large animal models. Read more. (On Penn Today)

Equalize 2020: A pitch competition & symposium to empower academic women entrepreneurs

Posted on — Jessica Jones Gupta

Equalize 2020 is a pitch competition and symposium designed to take national action around the disparity of women academic inventors forming university startups. This event will provide a platform to select, coach, and promote women inventors with startup technology to engage the investor and corporate community, building networks and creating a sustainable effort to drive…

Philadelphia: Here are your nominees for the 2019 Technical.ly Awards

Posted on October 8, 2019 — Jessica Jones Gupta

Voting is open for the awards in categories spanning startups, impact and inventions through Nov. 7, and join us for the celebration event on Dec. 12. Penn startups Lilu and Neuroflow are two of the nominees. Learn more and vote. (Technical.ly Philly)

People of PCI: Michael Yocum

Posted on September 27, 2019 — Jessica Jones Gupta

The Penn Center for Innovation is often the behind-the-scenes force promoting Penn discoveries, innovation, and technology. With this blog series, we’re moving the amazing PCI staff into the spotlight to learn about what they do, what led them to PCI, and how their work helps the greater Penn community. Our third spotlight shines on Michael…

Linnaeus Therapeutics announces FDA clearance of investigational new drug application for LNS8801

Posted on September 24, 2019 — Jessica Jones Gupta

Linnaeus Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company focused on the development and commercialization of novel, small molecule oncology therapeutics, announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug application (IND) for LNS8801, a small molecule agonist of the G protein-coupled estrogen receptor (GPER). Linnaeus is developing…

Turning the Tide: Fast fentanyl testing can save lives

Posted on September 23, 2019 — Jessica Jones Gupta

For the first responders treating a possible opioid overdose, it is vitally important to quickly identify the drug the patient took. A dosage of naloxone administered immediately to someone overdosing on fentanyl can bring them back from the brink and prevent long-term damage. Unfortunately, the recent influx of illegal fentanyl and fentanyl-laced drugs, means that…